At Innogene Kalbiotech we enrich diagnostics, therapeutics and health care products by bringing in the latest breakthroughs in biology and biotechnology. Our products carry our mission that transforms patients’ health and lives that we believe will work towards bettering life globally.

Racotumomab, a monoclonal antibody vaccine against stage III and IV lung cancer is now undergoing phase III clinical trial. The trial started in 2010 in The Philippines, Indonesia, Thailand and Singapore, and will go on to Malaysia and South Korea.